tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VRTX Stock Latest News

Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
RatingsVertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
2d ago
VRTX
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
16d ago
VRTX
Vertex Pharmaceuticals: Promising Advancements in Kidney Disease Treatments Drive Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Promising Advancements in Kidney Disease Treatments Drive Buy Rating
17d ago
VRTX
Vertex Pharmaceuticals presents new data on CASGEVY at ASH
PremiumThe Fly
Vertex Pharmaceuticals presents new data on CASGEVY at ASH
17d ago
VRTX
Vertex Pharmaceuticals price target raised to $564 from $516 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $564 from $516 at Morgan Stanley
19d ago
VRTX
Vertex Pharmaceuticals Positioned for Blockbuster Success in Rare Disease Market with Strong Renal Franchise and Promising Clinical Data
PremiumRatingsVertex Pharmaceuticals Positioned for Blockbuster Success in Rare Disease Market with Strong Renal Franchise and Promising Clinical Data
19d ago
VRTX
SPY ETF Daily Update, 12/3/2025
Premium
Market News
SPY ETF Daily Update, 12/3/2025
21d ago
L
BA
Midday Fly By: Anthropic starts work on IPO, Marvell reports Q3 beat
Premium
The Fly
Midday Fly By: Anthropic starts work on IPO, Marvell reports Q3 beat
21d ago
M
W
Oracle initiated, Uber upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Oracle initiated, Uber upgraded: Wall Street’s top analyst calls
21d ago
W
WEN
Vertex upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Vertex upgraded to Overweight from Equal Weight at Morgan Stanley
22d ago
VRTX
Vertex Pharmaceuticals: Strategic Diversification and Promising Pipeline Justify Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Strategic Diversification and Promising Pipeline Justify Buy Rating
22d ago
VRTX
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
1M ago
AZO
BMY
Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
PremiumThe FlyScotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
1M ago
BMY
JNJ
Vertex Pharmaceuticals initiated with an Outperform at Scotiabank
Premium
The Fly
Vertex Pharmaceuticals initiated with an Outperform at Scotiabank
1M ago
VRTX
Buy These 3 Stocks Now, Say Five-Star Analysts – November 11, 2025
Premium
Market News
Buy These 3 Stocks Now, Say Five-Star Analysts – November 11, 2025
1M ago
WMT
NVDA
Vertex Pharmaceuticals: Hold Rating Amid High Valuation and Uncertain Growth Prospects Beyond Cystic Fibrosis
PremiumRatings
Vertex Pharmaceuticals: Hold Rating Amid High Valuation and Uncertain Growth Prospects Beyond Cystic Fibrosis
1M ago
VRTX
Vertex Pharmaceuticals: Promising Growth in Renal Disease Market with Strong Clinical Data and Strategic Development
PremiumRatings
Vertex Pharmaceuticals: Promising Growth in Renal Disease Market with Strong Clinical Data and Strategic Development
1M ago
VRTX
Vertex Pharmaceuticals’ Promising Renal Franchise Developments Justify Buy Rating
PremiumRatings
Vertex Pharmaceuticals’ Promising Renal Franchise Developments Justify Buy Rating
1M ago
VRTX
Cautious Optimism: Hold Rating on Vertex Pharmaceuticals Amid Promising Clinical Trial Data
PremiumRatings
Cautious Optimism: Hold Rating on Vertex Pharmaceuticals Amid Promising Clinical Trial Data
1M ago
VRTX
Vertex Pharmaceuticals: Promising Data Amidst Competitive Renal Landscape and Investment Complexities
PremiumRatingsVertex Pharmaceuticals: Promising Data Amidst Competitive Renal Landscape and Investment Complexities
1M ago
VRTX
Vertex Pharmaceuticals announces updated data from RUBY-3 study of povetacicept
Premium
The Fly
Vertex Pharmaceuticals announces updated data from RUBY-3 study of povetacicept
2M ago
VRTX
Vertex Pharmaceuticals price target lowered to $546 from $553 at UBS
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $546 from $553 at UBS
2M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >